2 results match your criteria: "Coloproctology Clinical Management Unit[Affiliation]"
Reply to Balaphas et al.
Colorectal Dis
April 2021
Coloproctology Clinical Management Unit, General and Gastrointestinal Surgery Division, Seville, Spain.
Treatment of faecal incontinence with autologous expanded mesenchymal stem cells: results of a pilot study.
Colorectal Dis
March 2021
Andalusian Network for Design and Translation of Advanced Therapies, Seville, Spain.
Aim: Management of faecal incontinence (FI) remains challenging because no definitive optimal treatment for this condition has yet been determined. Regenerative medicine could be an attractive therapeutic alternative for treating FI. Here, we aimed to determine the safety and feasibility of autologous expanded mesenchymal stem cells derived from adipose tissue (AdMSCs) in the treatment of patients diagnosed with structural FI.
View Article and Find Full Text PDF